United States · FDA National Drug Code directory
Ustekinumab-aekn
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 51759-414_da99991a-7663-44b5-80f2-e22ffe92c54b
- Product NDC
- 51759-414
- Form
- INJECTION, SOLUTION
- Composition / generic term
- ustekinumab-aekn
- Labeler
- Teva Pharmaceuticals USA, Inc.
- Marketing category
- BLA
- Marketing start / end (source format)
- 20251223
- Source listing expiry
- 20271231
Source-listed ingredients
- USTEKINUMAB-AEKN — 90 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 TRAY in 1 CARTON (51759-414-32) / 1 SYRINGE, GLASS in 1 TRAY / 1 mL in 1 SYRINGE, GLASS · 51759-414-32
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →